RxSight (RXST) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on RxSight (RXST) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.32 of bullish evidence against -0.34 bearish.

RxSight last closed at $4.76, +1.71% on the session.

Against the IVW growth benchmark the position is +0.79% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

16 graded predictions for RXST so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks RxSight in the 28th percentile on return on equity, where 100 is best.

RxSight is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $194.66M.

StockMap tracks RxSight as the 94th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite RxSight ranks 95th of 133 in the group, against a group median of -0.21.